Author/Authors :
Taha, Mohamed E. Department of Internal Medicine - University of Nevada, Reno, NV, USA , Eljack, Ammar Department of Internal Medicine - Beaumont Health, Detroit, MI, USA , Ibrahim, Hisham Department of Internal Medicine - University of Iowa, IA, USA , Roongsritong, Chanwit Department of Heart and Vascular Health - Renown Regional Medical Center, Reno, NV, USA
Abstract :
The left atrial thrombus is a well-known complication of atrial fibrillation and rheumatic mitral valve disease and carries a high risk
for systemic thromboembolism. They are generally dissolved after a certain period of optimal anticoagulation. A large thrombus, on
the other hand, may persist even with adequate anticoagulation. The surgical removal of a thrombus theoretically poses some risk of
systemic embolization, making its management a clinical dilemma. Furthermore, a refractory thrombus is uncommon. Thus, an
evidence-based guideline in selecting the optimal therapy is needed. We report a case of a 74-year-old male with atrial
fibrillation and a history of unprovoked pulmonary embolism who was incidentally found to have a massive left atrial thrombus
shortly after discontinuing warfarin about 4 months following bioprosthetic aortic valve replacement. The thrombus was
refractory to anticoagulation posing a clinical management dilemma. This case is interesting in terms of presentation and the
approach to diagnosis and treatment.